{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:32:38Z","timestamp":1772119958274,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:00:00Z","timestamp":1326326400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s12028-011-9668-7","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T15:19:45Z","timestamp":1326295185000},"page":"299-305","source":"Crossref","is-referenced-by-count":62,"title":["Early Ketamine to Treat Refractory Status Epilepticus"],"prefix":"10.1007","volume":"16","author":[{"given":"Andreas H.","family":"Kramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,12]]},"reference":[{"key":"9668_CR1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","volume":"10","author":"AO Rossetti","year":"2011","unstructured":"Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922\u201330.","journal-title":"Lancet Neurol"},{"key":"9668_CR2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","volume":"43","author":"J Claassen","year":"2002","unstructured":"Claassen J, Hiersch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146\u201353.","journal-title":"Epilepsia"},{"key":"9668_CR3","first-page":"5511","volume":"25","author":"HP Goodkin","year":"2005","unstructured":"Goodkin HP, Yeh JL, Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurol. 2005;25:5511\u201320.","journal-title":"J Neurol"},{"key":"9668_CR4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(99)00238-4","volume":"265","author":"AM Mazarati","year":"1999","unstructured":"Mazarati AM, Wasterlain CG. N-methyl-d-aspartate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett. 1999;265:187\u201390.","journal-title":"Neurosci Lett"},{"key":"9668_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0920-1211(90)90025-Q","volume":"5","author":"J Kapur","year":"1990","unstructured":"Kapur J, Lothman EW. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures. Epilepsy Res. 1990;5:103\u201311.","journal-title":"Epilepsy Res"},{"key":"9668_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0920-1211(00)00175-3","volume":"42","author":"DJ Borris","year":"2000","unstructured":"Borris DJ, Bertram EH, Kapur J. Ketamine controls prolonged status epilepticus. Epilepsy Res. 2000;42:117\u201342.","journal-title":"Epilepsy Res"},{"key":"9668_CR7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/qjmed\/89.12.913","volume":"89","author":"MC Walker","year":"1996","unstructured":"Walker MC, Howard RS, Smith SJ, et al. Diagnosis and treatment of status epilepticus on a neurological intensive care unit. Q J Med. 1996;89:913\u201320.","journal-title":"Q J Med"},{"key":"9668_CR8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00008506-199707000-00012","volume":"9","author":"WA Kofke","year":"1997","unstructured":"Kofke WA, Bloom MJ, Van Cott A, Brenner RP. Electrographic tachyphylaxis to etomidate and ketamine used for refractory status epilepticus controlled with isoflurane. J Neurosurg Anesthesiol. 1997;9:269\u201372.","journal-title":"J Neurosurg Anesthesiol"},{"key":"9668_CR9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1212\/WNL.51.6.1765","volume":"51","author":"RD Sheth","year":"1998","unstructured":"Sheth RD, Gidal BE. Refractory status epilepticus: response to ketamine. Neurology. 1998;51:1765\u20136.","journal-title":"Neurology"},{"key":"9668_CR10","first-page":"A197","volume":"3","author":"B Nathan","year":"2002","unstructured":"Nathan B, Smith TL, Bleck TB. The use of ketamine in the treatment of refractory status epilepticus. Neurology. 2002;3:A197.","journal-title":"Neurology"},{"key":"9668_CR11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S1525-5050(02)00643-1","volume":"4","author":"EE Ubogu","year":"2003","unstructured":"Ubogu EE, Sagar SM, Lerner AJ, et al. Ketamine for refractory status epilepticus: a case of possible ketamine-induced neurotoxicity. Epilepsy Behav. 2003;4:70\u20135.","journal-title":"Epilepsy Behav"},{"key":"9668_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.eplepsyres.2008.08.005","volume":"82","author":"H Pruss","year":"2008","unstructured":"Pruss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Res. 2008;82:219\u201322.","journal-title":"Epilepsy Res"},{"key":"9668_CR13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0b013e3181d1e3cd","volume":"33","author":"CY Hsieh","year":"2010","unstructured":"Hsieh CY, Sung PS, Tsai JJ, Huang CW. Terminating prolonged refractory status epilepticus using ketamine. Clin Neuropharm. 2010;33:165\u20137.","journal-title":"Clin Neuropharm"},{"key":"9668_CR14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.seizure.2011.06.001","volume":"20","author":"PS Yeh","year":"2011","unstructured":"Yeh PS, Shen HN, Chen TY. Oral ketamine controlled refractory nonconvulsive status epilepticus in an elderly patient. Seizure. 2011;20:723\u20136.","journal-title":"Seizure"},{"key":"9668_CR15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1212\/WNL.0b013e3181f9619e","volume":"75","author":"CP Stewart","year":"2010","unstructured":"Stewart CP, Otsubo H, Ochi A, et al. Seizure identification in the ICU using quantitative EEG displays. Neurology. 2010;75:1501\u20138.","journal-title":"Neurology"},{"key":"9668_CR16","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/archneurol.2011.240","volume":"68","author":"SB Ko","year":"2011","unstructured":"Ko SB, Ortega-Gutierrez S, Choi HA, et al. Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest. Arch Neurol. 2011;68:1323\u20136.","journal-title":"Arch Neurol"},{"key":"9668_CR17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1006\/ebeh.2001.0272","volume":"2","author":"LS Stewart","year":"2001","unstructured":"Stewart LS, Persinger MA. Ketamine prevents learning impairment when administered immediately after status epilepticus onset. Epilepsy Behav. 2001;2:585\u201391.","journal-title":"Epilepsy Behav"},{"key":"9668_CR18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2007.01384.x","volume":"49","author":"BS Martin","year":"2008","unstructured":"Martin BS, Kapur J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia. 2008;49:248\u201355.","journal-title":"Epilepsia"},{"key":"9668_CR19","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1097\/CCM.0b013e3181b08ac7","volume":"37","author":"VN Iyer","year":"2009","unstructured":"Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37:3024\u201330.","journal-title":"Crit Care Med"},{"key":"9668_CR20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.0013-9580.2004.01904.x","volume":"45","author":"AO Rossetti","year":"2004","unstructured":"Rossetti AO, Reichhart MD, Schaller MD, et al. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004;45:757\u201363.","journal-title":"Epilepsia"},{"key":"9668_CR21","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00134-003-1905-x","volume":"29","author":"B Vasile","year":"2003","unstructured":"Vasile B, Rasulo F, Candiani A, Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417\u201325.","journal-title":"Intensive Care Med"},{"key":"9668_CR22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1059-1311(03)00028-1","volume":"12","author":"LD Mewasingh","year":"2003","unstructured":"Mewasingh LD, Skhara T, Aeby A, et al. Oral ketamine in paediatric non-convulsive status epilepticus. Seizure. 2003;12:483\u20139.","journal-title":"Seizure"},{"key":"9668_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/08830738050200030301","volume":"20","author":"U Kramer","year":"2005","unstructured":"Kramer U, Shorer Z, Ben-Zeev B, et al. Severe refractory status epilepticus owing to presumed encephalitis. J Child Neurol. 2005;20:184\u20137.","journal-title":"J Child Neurol"},{"key":"9668_CR24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/35002090","volume":"403","author":"DJ Rossi","year":"2000","unstructured":"Rossi DJ, Oshima T, Attwell D. Glutamate release in severe brain ischaemia is mainly be reversed uptake. Nature. 2000;403:316\u201321.","journal-title":"Nature"},{"key":"9668_CR25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091\u20138.","journal-title":"Lancet Neurol"},{"key":"9668_CR26","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/WNL.0b013e31821b7cc9","volume":"76","author":"EE Benarroch","year":"2011","unstructured":"Benarroch EE. NMDA receptors: recent insights and clinical correlations. Neurology. 2011;76:1750\u20137.","journal-title":"Neurology"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-011-9668-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12028-011-9668-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-011-9668-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:14:31Z","timestamp":1559427271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12028-011-9668-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,12]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["9668"],"URL":"https:\/\/doi.org\/10.1007\/s12028-011-9668-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.716298013.791902809","asserted-by":"object"}]},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,12]]}}}